<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[GlaxoSmithKline is pleased to announce the launch of two new packs of Arzerra in the UK containing a revised formulation of the product containing an acetate-based buffer.  These packs replace existin]]></title><description><![CDATA[<p dir="auto">GlaxoSmithKline is pleased to announce the launch of two new packs of Arzerra in the UK containing a revised formulation of the product containing an acetate-based buffer.  These packs replace existing packs, which contain a citrate-based buffer.  The switch to the new buffer has been undertaken to further enhance the stability of the product by minimizing particle formation.</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/448355/glaxosmithkline-is-pleased-to-announce-the-launch-of-two-new-packs-of-arzerra-in-the-uk-containing-a-revised-formulation-of-the-product-containing-an-acetate-based-buffer-these-packs-replace-existin</link><generator>RSS for Node</generator><lastBuildDate>Sat, 20 Jun 2026 08:49:30 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/448355.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 04 Jul 2011 09:23:56 GMT</pubDate><ttl>60</ttl></channel></rss>